Officials hope the protein-based vaccine will appeal to the nearly 22% of Americans who have not received a single dose of a Covid-19 inoculation.
Officials hope the protein-based vaccine will appeal to the nearly 22% of Americans who have not received a single dose of a Covid-19 inoculation.